Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Report 2021

1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Overview

• 1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Scope
• 1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type
  • 1.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Control Hyperphosphatemia
  • 1.2.3 Maintain Blood Calcium Levels
  • 1.2.4 Control PTH Level
  • 1.2.5 Correct Acidosis
  • 1.2.6 Other
• 1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
  • 1.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
  • 1.3.5 Drug Stores
  • 1.3.6 Other
• 1.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Trends (2016-2027)

2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Estimates and Forecasts by Region

• 2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2016-2021)
• 2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Estimates and Projections (2016-2027)
  • 2.4.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Estimates and Projections (2016-2027)
  • 2.4.3 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Estimates and Projections (2016-2027)
  • 2.4.4 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Estimates and Projections (2016-2027)
  • 2.4.6 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Estimates and Projections (2016-2027)

3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Competition Landscape by Players

• 3.1 Global Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players by Sales (2016-2021)
• 3.2 Global Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players by Revenue (2016-2021)
• 3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) as of 2020)
• 3.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price by Company (2016-2021)
• 3.5 Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type

• 4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2016-2021)
• 4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Type (2022-2027)

5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application

• 5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2016-2021)
• 5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Application (2022-2027)

6 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures

• 6.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company
  • 6.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2016-2021)
  • 6.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2016-2021)
• 6.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type
  • 6.2.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2022-2027)
• 6.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application
  • 6.3.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2022-2027)

7 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures

• 7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company
  • 7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2016-2021)
  • 7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2016-2021)
• 7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type
  • 7.2.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2022-2027)
• 7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application
  • 7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures

• 8.1 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company
  • 8.1.1 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2016-2021)
  • 8.1.2 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2016-2021)
• 8.2 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type
  • 8.2.1 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2022-2027)
• 8.3 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application
  • 8.3.1 China 316 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures

• 9.1 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company
  • 9.1.1 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2016-2021)
  • 9.1.2 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2016-2021)
• 9.2 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type
  • 9.2.1 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2022-2027)
• 9.3 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application
  • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures

• 10.1 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company
  • 10.1.1 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2016-2021)
• 10.2 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type
  • 10.2.1 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application
  • 10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures

• 11.1 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company
  • 11.1.1 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2016-2021)
  • 11.1.2 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2016-2021)
• 11.2 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type
  • 11.2.1 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Type (2022-2027)
• 11.3 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application
  • 11.3.1 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Business

• 12.1 Akebia
  • 12.1.1 Akebia Corporation Information
  • 12.1.2 Akebia Business Overview
  • 12.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.1.5 Akebia Recent Development
• 12.2 Astellas
  • 12.2.1 Astellas Corporation Information
  • 12.2.2 Astellas Business Overview
  • 12.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.2.5 Astellas Recent Development
• 12.3 Takeda
  • 12.3.1 Takeda Corporation Information
  • 12.3.2 Takeda Business Overview
  • 12.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.3.5 Takeda Recent Development
• 12.4 Vifor
  • 12.4.1 Vifor Corporation Information
  • 12.4.2 Vifor Business Overview
  • 12.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.4.5 Vifor Recent Development
• 12.5 Abbvie
  • 12.5.1 Abbvie Corporation Information
  • 12.5.2 Abbvie Business Overview
  • 12.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.5.5 Abbvie Recent Development
• 12.6 Fresenius
  • 12.6.1 Fresenius Corporation Information
  • 12.6.2 Fresenius Business Overview
  • 12.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.6.5 Fresenius Recent Development
• 12.7 Abbott
  • 12.7.1 Abbott Corporation Information
  • 12.7.2 Abbott Business Overview
  • 12.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.7.5 Abbott Recent Development
• 12.8 Novadiol
  • 12.8.1 Novadiol Corporation Information
  • 12.8.2 Novadiol Business Overview
  • 12.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.8.5 Novadiol Recent Development
• 12.9 Japan Tobacco Company
  • 12.9.1 Japan Tobacco Company Corporation Information
  • 12.9.2 Japan Tobacco Company Business Overview
  • 12.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.9.5 Japan Tobacco Company Recent Development
• 12.10 Daiichi-Sankyo
  • 12.10.1 Daiichi-Sankyo Corporation Information
  • 12.10.2 Daiichi-Sankyo Business Overview
  • 12.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.10.5 Daiichi-Sankyo Recent Development
• 12.11 Shield
  • 12.11.1 Shield Corporation Information
  • 12.11.2 Shield Business Overview
  • 12.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.11.5 Shield Recent Development
• 12.12 Spectrum
  • 12.12.1 Spectrum Corporation Information
  • 12.12.2 Spectrum Business Overview
  • 12.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.12.5 Spectrum Recent Development
• 12.13 OPKO
  • 12.13.1 OPKO Corporation Information
  • 12.13.2 OPKO Business Overview
  • 12.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.13.5 OPKO Recent Development
• 12.14 Ardelyx
  • 12.14.1 Ardelyx Corporation Information
  • 12.14.2 Ardelyx Business Overview
  • 12.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.14.5 Ardelyx Recent Development
• 12.15 Sanofi Genzyme
  • 12.15.1 Sanofi Genzyme Corporation Information
  • 12.15.2 Sanofi Genzyme Business Overview
  • 12.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.15.5 Sanofi Genzyme Recent Development
• 12.16 Amgen
  • 12.16.1 Amgen Corporation Information
  • 12.16.2 Amgen Business Overview
  • 12.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
  • 12.16.5 Amgen Recent Development

13 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Cost Analysis

• 13.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
• 13.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
• 14.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers

15 Market Dynamics

• 15.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Trends
• 15.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Drivers
• 15.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges
• 15.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List